Esperion Therapeutics Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan '26 Jan 22, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	672	419	308	430	269	593
Market Cap Growth	58.73%	36.11%	-28.38%	59.59%	-54.57%	-59.20%
Enterprise Value	1,100	819	685	762	639	562
Last Close Price	2.86	1.99	2.84	5.42	4.19	21.84
PS Ratio	2.59	1.30	2.92	6.08	3.90	3.19
PB Ratio	-1.75	-1.11	-0.75	-1.42	-1.55	-7.54
EV/Sales Ratio	4.30	2.55	6.51	10.79	9.26	3.02
EV/EBITDA Ratio	-	15.58	-	-	-	-
EV/EBIT Ratio	-	15.59	-	-	-	-
Debt / Equity Ratio	-1.33	-1.52	-1.19	-1.56	-2.63	-3.77
Debt / EBITDA Ratio	-	10.29	-	-	-	-
Asset Turnover	0.90	1.21	0.51	0.24	0.21	0.80
Inventory Turnover	1.55	1.43	2.57	4.19	4.76	-
Quick Ratio	0.59	0.91	0.84	2.17	3.85	3.37
Current Ratio	1.00	1.37	1.29	2.67	4.49	3.68
Return on Assets (ROA)	-5.42%	12.37%	-42.86%	-35.64%	-36.31%	-26.73%
Return on Capital Employed (ROCE)	-589.10%	55.70%	-313.80%	-115.30%	-69.30%	-46.80%
Earnings Yield	-13.43%	-11.94%	-61.54%	-50.90%	-87.91%	-19.81%
FCF Yield	-	-5.53%	-39.85%	-38.09%	-86.18%	-11.87%
Buyback Yield / Dilution	-18.70%	-81.54%	-55.26%	-129.76%	-5.20%	-1.42%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.